Humacyte, Inc. (HUMA) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.07
-1.39%
Mkt Cap $141.39M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $1.35M | $467.00K | -65.39% | -$0.13 | -$0.13 | +0.00% |
| Q4 2025 Nov 12, 2025 | $1.35M | $753.00K | -44.18% | -$0.17 | -$0.14 | +17.65% |
| Q3 2025 Aug 11, 2025 | $917.83K | $301.00K | -67.21% | -$0.15 | -$0.24 | -60.00% |
| Q2 2025 May 13, 2025 | $764.83K | $517.00K | -32.40% | -$0.19 | -$0.10 | +47.37% |
| Q1 2025 Mar 28, 2025 | $640.20K | $7.23M | +1029.02% | -$0.23 | -$0.16 | +30.43% |
| Q4 2024 Nov 8, 2024 | $214.29K | — | — | -$0.26 | -$0.33 | -26.92% |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.23 | -$0.27 | -17.39% |
| Q2 2024 May 10, 2024 | — | — | — | -$0.23 | -$0.29 | -26.09% |
| Q1 2024 Mar 22, 2024 | $60.00K | $10.79M | +17883.33% | -$0.25 | -$0.24 | +4.00% |
| Q4 2023 Nov 9, 2023 | $70.00K | — | — | -$0.25 | -$0.25 | +0.00% |
| Q3 2023 Aug 14, 2023 | $70.00K | — | — | -$0.22 | -$0.22 | +0.00% |
| Q2 2023 May 12, 2023 | $170.00K | — | — | -$0.22 | -$0.22 | +0.00% |
| Q1 2023 Mar 24, 2023 | $200.00K | $5.00K | -97.50% | -$0.24 | -$0.21 | +12.50% |
| Q4 2022 Nov 10, 2022 | $203.50K | $31.00K | -84.77% | -$0.21 | -$0.25 | -19.05% |
| Q3 2022 Aug 12, 2022 | $235.40K | $1.30M | +452.68% | -$0.22 | -$0.19 | +13.64% |
| Q2 2022 May 13, 2022 | $235.40K | $233.00K | -1.02% | -$0.21 | -$0.22 | -4.76% |
| Q1 2022 Mar 29, 2022 | $245.67K | $177.00K | -27.95% | -$0.19 | -$0.22 | -15.79% |
| Q4 2021 Nov 12, 2021 | — | $241.00K | — | -$0.21 | -$0.72 | -242.86% |
| Q3 2021 Aug 16, 2021 | — | $690.00K | — | -$0.56 | -$0.17 | +70.18% |
| Q2 2021 May 17, 2021 | — | $155.00K | — | -$0.90 | -$0.20 | +77.78% |
| Q1 2021 Feb 16, 2021 | — | $124.00K | — | — | -$5.61 | — |
| Q4 2020 Nov 12, 2020 | — | $914.00K | — | — | -$1.43 | — |
| Q2 2020 Jun 30, 2020 | — | $198.00K | — | — | -$0.68 | — |
| Q1 2020 Mar 31, 2020 | — | $255.00K | — | — | -$0.81 | — |